JP5726662B2 - 血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 - Google Patents
血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 Download PDFInfo
- Publication number
- JP5726662B2 JP5726662B2 JP2011161112A JP2011161112A JP5726662B2 JP 5726662 B2 JP5726662 B2 JP 5726662B2 JP 2011161112 A JP2011161112 A JP 2011161112A JP 2011161112 A JP2011161112 A JP 2011161112A JP 5726662 B2 JP5726662 B2 JP 5726662B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- impedance
- electrodes
- circuit
- pair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims description 250
- 239000008280 blood Substances 0.000 title claims description 250
- 238000000502 dialysis Methods 0.000 title claims description 25
- 238000000034 method Methods 0.000 title claims description 16
- 239000011347 resin Substances 0.000 claims description 38
- 229920005989 resin Polymers 0.000 claims description 38
- 239000012212 insulator Substances 0.000 claims description 30
- 238000001514 detection method Methods 0.000 claims description 25
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000011017 operating method Methods 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 description 26
- 210000000601 blood cell Anatomy 0.000 description 23
- 210000000170 cell membrane Anatomy 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 239000000306 component Substances 0.000 description 16
- 210000002977 intracellular fluid Anatomy 0.000 description 15
- 210000003722 extracellular fluid Anatomy 0.000 description 14
- 238000005534 hematocrit Methods 0.000 description 14
- 239000000815 hypotonic solution Substances 0.000 description 12
- 230000003204 osmotic effect Effects 0.000 description 12
- 239000000819 hypertonic solution Substances 0.000 description 11
- 229940021223 hypertonic solution Drugs 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 239000003990 capacitor Substances 0.000 description 8
- 238000002847 impedance measurement Methods 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 239000003792 electrolyte Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000012806 monitoring device Methods 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000001631 haemodialysis Methods 0.000 description 4
- 230000000322 hemodialysis Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010014357 Electric shock Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 239000002441 uremic toxin Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 241001227124 Dialytes Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940037395 electrolytes Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 230000010220 ion permeability Effects 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- External Artificial Organs (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011161112A JP5726662B2 (ja) | 2011-07-22 | 2011-07-22 | 血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011161112A JP5726662B2 (ja) | 2011-07-22 | 2011-07-22 | 血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013022310A JP2013022310A (ja) | 2013-02-04 |
| JP2013022310A5 JP2013022310A5 (https=) | 2014-09-04 |
| JP5726662B2 true JP5726662B2 (ja) | 2015-06-03 |
Family
ID=47781313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011161112A Expired - Fee Related JP5726662B2 (ja) | 2011-07-22 | 2011-07-22 | 血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5726662B2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2014156370A1 (ja) * | 2013-03-29 | 2017-02-16 | ソニー株式会社 | 血液状態評価装置、血液状態評価システム、血液状態評価方法及びプログラム |
| EP3111837B1 (en) * | 2014-02-25 | 2020-10-28 | School Juridical Person The Kitasato Institute | Image generating device and image generating method |
| JP5791132B1 (ja) * | 2014-04-07 | 2015-10-07 | 学校法人北里研究所 | 検知装置、検知システム、検知方法およびプログラム |
| JP2016174752A (ja) * | 2015-03-20 | 2016-10-06 | ソニー株式会社 | 血液状態監視装置、血液状態を監視する方法、血液状態監視システム、及び血液状態改善用プログラム |
| JP7108615B2 (ja) | 2017-07-21 | 2022-07-28 | 日機装株式会社 | 血液浄化装置 |
| KR102928834B1 (ko) | 2020-03-25 | 2026-02-20 | 삼성전자주식회사 | 체내 물질 성분 분석 장치 및 방법과, 임피던스 측정 장치 |
| CN117531058A (zh) * | 2023-12-15 | 2024-02-09 | 北京航空航天大学 | 一种用于血液原位监测的医学装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2067572A5 (https=) * | 1969-11-07 | 1971-08-20 | Aura | |
| JPH064093B2 (ja) * | 1986-03-05 | 1994-01-19 | グラム株式会社 | 限外濾過量及び透析液濃度測定装置 |
| JPS63133062A (ja) * | 1986-11-25 | 1988-06-04 | Toyota Central Res & Dev Lab Inc | ヘマトクリツト測定装置 |
| AU5383796A (en) * | 1995-04-20 | 1996-11-07 | Microcor, Inc. | Method and apparatus for noninvasively determining hematocri t |
| JPH1033662A (ja) * | 1996-07-25 | 1998-02-10 | Kanegafuchi Chem Ind Co Ltd | 血液体外循環装置 |
| IT1308687B1 (it) * | 1999-12-28 | 2002-01-09 | Gambro Dasco Spa | Metodo e dispositivo di rilevamento dell'accesso al sistemacardivascolare in un trattamento extracorporeo del sangue in una |
| US8376978B2 (en) * | 2007-02-09 | 2013-02-19 | Baxter International Inc. | Optical access disconnection systems and methods |
-
2011
- 2011-07-22 JP JP2011161112A patent/JP5726662B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013022310A (ja) | 2013-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5726662B2 (ja) | 血液インピーダンス計測装置、人工透析装置及び血液のインピーダンスを計測する装置の作動方法 | |
| US9823207B2 (en) | Method and device for determining intracellular and/or extracellular, in particular macromolecular fractions of fluids, preferably of body fluids of living organisms | |
| JP6362267B2 (ja) | 体外血液処理の動作状態を検出するためのデバイス及び方法 | |
| JP6283363B2 (ja) | 体外血液処置中に再循環を検出するためのデバイスおよび方法 | |
| US6980852B2 (en) | Film barrier dressing for intravascular tissue monitoring system | |
| JP2020044392A5 (https=) | ||
| EP1800703A1 (en) | Blood dialyzing apparatus | |
| JPH0399254A (ja) | ヘマトクリット測定装置 | |
| US12276628B2 (en) | Systems and methods for measuring electrical characteristic of medical fluids | |
| Ravagli et al. | Noninvasive estimation of plasma sodium concentration during hemodialysis via capacitively coupled electrical impedance spectroscopy | |
| CN209529783U (zh) | 用于干重的透析后确定的系统 | |
| US20090118666A1 (en) | Method and implantable device for measuring hematocrit | |
| US20240358905A1 (en) | Systems and methods for measuring electrical characteristic of medical fluids | |
| CN111225694A (zh) | 血液净化装置 | |
| JP7808172B1 (ja) | 血液浄化装置 | |
| JP7839856B1 (ja) | 血液浄化装置 | |
| US11419963B2 (en) | Blood purification apparatus | |
| JP7839855B1 (ja) | 血液浄化装置 | |
| Nakaya et al. | Investigation of Electrical Characteristics in Novel Needle Dislodgement Detection Electrodes for Dialysis Therapy | |
| HK40092568A (zh) | 用於测量医用流体的电特性的系统和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140716 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140716 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141211 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150213 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150303 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150401 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5726662 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |